Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.
Dodick DW, Goadsby PJ, Silberstein SD, Lipton RB, Olesen J, Ashina M, Wilks K, Kudrow D, Kroll R, Kohrman B, Bargar R, Hirman J, Smith J; ALD403 study investigators. Dodick DW, et al. Among authors: wilks k. Lancet Neurol. 2014 Nov;13(11):1100-1107. doi: 10.1016/S1474-4422(14)70209-1. Epub 2014 Oct 5. Lancet Neurol. 2014. PMID: 25297013 Clinical Trial.
Diagnostic lessons from the spectrum study.
Lipton RB, Cady RK, Stewart WF, Wilks K, Hall C. Lipton RB, et al. Among authors: wilks k. Neurology. 2002 May 14;58(9 Suppl 6):S27-31. doi: 10.1212/wnl.58.9_suppl_6.s27. Neurology. 2002. PMID: 12011271 Review.
COVID-19 in a complex obstetric patient with cystic fibrosis.
Walczak A, Wilks K, Shakhovskoy R, Baird T, Schlebusch S, Taylor C, Reid D, Choong K. Walczak A, et al. Among authors: wilks k. Infect Dis Health. 2020 Nov;25(4):239-241. doi: 10.1016/j.idh.2020.07.002. Epub 2020 Jul 23. Infect Dis Health. 2020. PMID: 32763024 Free PMC article.
42 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page